Medicines A-Z
Back to Fosbu V Tablet (Sofosbuvir + Velpatasvir)

Fosbu V (Sofosbuvir + Velpatasvir) Uses in Pakistan

Fosbu V (Sofosbuvir + Velpatasvir) is prescribed by specialist hepatologists in Pakistan for the treatment of Hepatitis C. This guide covers all approved uses, indications, and essential information about Fosbu V.

Compiled by the PakVita Editorial Team · AI-assisted drafting with editorial review · Sourced from DRAP, WHO, BNF · Last updated:

Uses

Quick Answer

Fosbu V (Sofosbuvir + Velpatasvir) is used to treat chronic Hepatitis C virus (HCV) infection of all genotypes (1–6) in adults. It works in both cirrhotic and non-cirrhotic patients, treatment-naive and treatment-experienced. Always take it under a hepatologist's supervision for a 12-week course (or longer for decompensated cirrhosis with Ribavirin).

Primary Uses at a Glance

Chronic Hepatitis C — All Genotypes (1–6)

Fosbu V is pan-genotypic — it works against all 6 main genotypes of Hepatitis C. It is the preferred first-line regimen for HCV treatment in Pakistan because it can be used without genotype testing. Sofosbuvir blocks NS5B RNA polymerase; Velpatasvir inhibits the NS5A replication complex — together they effectively halt HCV replication.

As prescribed by hepatologist. Standard adult dose: one tablet daily for 12 weeks.

Compensated Cirrhosis (Child-Pugh A)

Fosbu V is also used in liver cirrhosis patients whose liver function is relatively preserved (Child-Pugh A). These patients can achieve a Sustained Virologic Response (SVR) with 12-week monotherapy, which is practically considered an HCV cure.

As prescribed by hepatologist. One tablet daily for 12 weeks.

Decompensated Cirrhosis (Child-Pugh B/C) with Ribavirin

In patients with severe liver disease, Fosbu V is used together with Ribavirin. The dose of Ribavirin is weight-based and determined by the doctor. Treatment duration is 12 weeks but the hepatologist may extend it to 24 weeks. Ribavirin is teratogenic — both men and women should seek guidance from the doctor regarding contraception.

As prescribed by hepatologist. One tablet Fosbu V + Ribavirin (weight-based) daily.

Other Uses

  • Treatment-experienced HCV patients
  • HCV-HIV co-infection

Fosbu V (Sofosbuvir + Velpatasvir) Uses (Fayde / Kis kaam aati hai)

Fosbu V contains Sofosbuvir (400mg) + Velpatasvir (100mg) and belongs to the Pan-genotypic Hepatitis C Antiviral group. In Pakistan it is among the top choices of hepatologists for treating Hepatitis C.

Primary Uses (Mukhya Istemal)

  • Chronic Hepatitis C infection — all genotypes (1–6)
  • Compensated cirrhosis (Child-Pugh A) — 12 weeks monotherapy
  • Decompensated cirrhosis (Child-Pugh B/C) — with Ribavirin for 12–24 weeks
  • Treatment-naive patients — first-time HCV treatment
  • Treatment-experienced patients — after prior regimens

Who Should Take It (Kin logon ke liye)

  • Adults diagnosed with chronic HCV infection
  • Cirrhotic patients — compensated or decompensated
  • Patients who previously received HCV treatment but were not cured
  • HCV/HIV co-infected patients

When NOT to Use Fosbu V (Kab nahi leni chahiye)

  • Patients using Amiodarone — risk of fatal bradycardia (CONTRAINDICATED)
  • If allergic to Sofosbuvir or Velpatasvir
  • With Rifampicin or St. John's Wort — efficacy may be reduced
  • Never take without a hepatologist's prescription

Summary

Fosbu V is one of the most essential medicines for Hepatitis C in Pakistan. It is effective across all genotypes 1 to 6 — in both cirrhotic and non-cirrhotic patients, and in both treatment-naive and experienced groups. Always use under a hepatologist's supervision.

The information in this guide is for educational purposes only.

Frequently Asked Questions

Sofosbuvir velpatasvir kis kaam aata hai?

Fosbu V (Sofosbuvir + Velpatasvir) is used against all genotypes (1 to 6) of Hepatitis C virus (HCV). It is a pan-genotypic antiviral that stops HCV replication in the liver. Always take it under a hepatologist's supervision.

Kya Fosbu V sirf ek genotype ke liye hai?

No — Fosbu V is pan-genotypic, meaning it is approved for HCV genotypes 1, 2, 3, 4, 5, and 6. This is why hepatologists often prefer it, as treatment can be started without waiting for genotype test results.

Treatment-naive aur treatment-experienced mein farq kya hai?

A treatment-naive patient is one who has never previously received HCV treatment. A treatment-experienced patient has already taken interferon, Sofosbuvir, or other HCV medicines. Fosbu V is effective for both groups, but the dose and combination are determined by the hepatologist.

Kya Fosbu V cirrhosis mein safe hai?

Yes, Fosbu V monotherapy is approved for compensated cirrhosis (Child-Pugh A). In decompensated cirrhosis (Child-Pugh B/C) it is used together with Ribavirin — with closer monitoring. This decision can only be made by a hepatologist.

Kya Fosbu V HCV permanently khatam kar deti hai?

In most patients, a Sustained Virologic Response (SVR) is achieved after a 12-week course — this is practically considered an HCV cure. It is confirmed by a PCR test 12 weeks after completing treatment. Stopping the course early can eliminate the chance of achieving SVR.

Sources

  1. DRAP Registered Products Database — Drug Regulatory Authority of Pakistan
  2. WHO Model List of Essential Medicines, 23rd ed. (2023) — World Health Organization
  3. British National Formulary (BNF) — BMJ Group & Pharmaceutical Press

Medical disclaimer

This page is for educational use only and does not replace professional medical advice. Always confirm diagnosis, dose, and interactions with a qualified doctor or pharmacist before starting or changing any medicine.